CASE STUDY
Virtual Ad Board
Actionable payer, physician & patient insights to optimize access strategy
Situation
A top 10 global pharma with an innovative Cell Therapy pipeline, our client needed to be able to work with target health care systems and understand how to demonstrate value and to solve the pricing challenge for these innovative and expensive treatments.
They asked AESARA to run an advisory board with experts from health policy, providers, patient advocates and payers. Given COVID19 global travel restrictions, the advisory board needed to be conducted in the online setting.
Action
- AESARA worked with the client’s global market access and policy team to develop content and execute a Payer Advisory Board aimed at informing and providing insights to how the client might meet these unique challenges in Cell Therapy.
- Leveraging our excellent global network of payer and policy-maker, AESARA curated a targeted panel of experts unique to the client’s need.
- Having held roles in industry like our clients’, our expert strategy consultants led development of advisory board objectives, agenda, questions and presentation content, with a focus on maximizing the value gained from time with the external experts.
- Additionally, as the digital-forward market access agency, we deployed best-in-class digital creativity and the essential human touch, to optimize the client and expert experience for an ad board in the online setting.
Enabling Activity
Payer research and ad boards
Region
U.S.
Client
Market Access Team
IMPACT
The expert insights gained from the Advisory Board on CAR-T products’ pricing, access and policy challenges helped:
- Inform recommendations for pivotal study design
- Shape go-to-market strategies, proactive CMS coding strategies, ICER engagement, and early payer engagement plan
- Identify practical hurdles and possible solutions in establishing the value and price connection for achieving next generation cell therapy value, price and access goals.
